Company / Operating Cash Flow per Share
Zivo Bioscience, Inc. Operating Cash Flow per Share History
FY2013-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.81
FY2024
5-year range
-$3.69 / -$0.01
FY2020-FY2024
Trend
+51.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-3.69 in FY2023 to $-0.01 in FY2020.
Based on SEC 10-K filings.
-1.81 in FY2024.
Declined from $-0.75 to $-1.81 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, operating cash flow per share increased 51.0% year-over-year.
- Peak operating cash flow per share was recorded in FY2020.
- Lowest operating cash flow per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -96.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$1.81 | +51.0% |
| FY2023 | -$3.69 | -390.0% |
| FY2022 | -$0.75 | +42.8% |
| FY2021 | -$1.32 | -20927.0% |
| FY2020 | -$0.01 | +69.6% |
| FY2019 | -$0.02 | -7.0% |
| FY2016 | -$0.02 | -7.9% |
| FY2015 | -$0.02 | +23.8% |
| FY2014 | -$0.02 | +17.4% |
| FY2013 | -$0.03 | -60.0% |
As of FY2024 · SEC 10-K · Updated Jun 29, 2026